Have a personal or library account? Click to login
Potential Usefulness of IgA for the Early Detection of SARS-CoV-2 Infection: Comparison With IgM Cover

Potential Usefulness of IgA for the Early Detection of SARS-CoV-2 Infection: Comparison With IgM

Polish Journal of Microbiology
Volume 73 (2024): Issue 2 (June 2024)
By: Pei Wang  
Open Access
|Jun 2024

References

  1. Anis S, Khan MA, Fatima A, Kanani F, Aijaz J, Hussain A, Sarfaraz S. Significance of Anti-COVID-IgA antibody response in COVID-19 breakthrough infection in vaccinated patients – a single-centered study from Pakistan. Immunol Res. 2023 Dec;71(6):941–949. https://doi.org/10.1007/s12026-023-09407-y
    Search in Google ScholarBack to article
  2. Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, Fazlalipour M, Pouriayevali MH, Jalali T, Mousavi Nasab SD, et al; SARS CoV-2 Rapid Response Team of Pasteur Institute of Iran (PII). Severe acute respiratory syndromecoronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects. Rev Med Virol. 2021 May;31(3):e2183. https://doi.org/10.1002/rmv.2183
    Search in Google ScholarBack to article
  3. Arkhipova-Jenkins I, Helfand M, Armstrong C, Gean E, Anderson J, Paynter RA, Mackey K. Antibody response after SARS-CoV-2 infection and implications for immunity: A rapid living review. Ann Intern Med. 2021 Jun;174(6):811–821. https://doi.org/10.7326/M20-7547
    Search in Google ScholarBack to article
  4. Burbelo PD, Riedo FX, Morishima C, Rawlings S, Smith D, Das S, Strich JR, Chertow DS, Davey RT, Cohen JI. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. J Infect Dis. 2020 Jun;222(2):206–213. https://doi.org/10.1093/infdis/jiaa273
    Search in Google ScholarBack to article
  5. Cacaci M, Menchinelli G, Ricci R, De Maio F, Mariotti M, Torelli R, Morandotti GA, Bugli F, Sanguinetti M, Posteraro B. Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay. Clin Microbiol Infect. 2021 Jan;27(5):808–810. https://doi.org/10.1016/j.cmi.2020.12.014
    Search in Google ScholarBack to article
  6. Casian JG, Angel AN, Lopez R, Bagos C, MacMullan MA, Bui ML, Chellamathu P, Das S, Turner F, Slepnev V, et al. Saliva-based ELISAs for effective SARS-CoV-2 antibody monitoring in vaccinated individuals. Front Immunol. 2021 Sep;12:701411. https://doi.org/10.3389/fimmu.2021.701411
    Search in Google ScholarBack to article
  7. Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, Raeber ME, Adamo S, Weigang S, Emmenegger M, et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol. 2021 Feb;147(2):545–557.e9. https://doi.org/10.1016/j.jaci.2020.10.040
    Search in Google ScholarBack to article
  8. De-Simone SG, Napoleão-Pêgo P, Lechuga GC, Carvalho JPRS, Monteiro ME, Morel CM, Provance DW Jr. Mapping IgA epitope and cross-reactivity between severe acute respiratory syndrome-associated coronavirus 2 and DENV. Vaccines (Basel). 2023 Nov;11(12):1749. https://doi.org/10.3390/vaccines11121749
    Search in Google ScholarBack to article
  9. Drummer HE, Van H, Klock E, Zheng S, Wei Z, Boo I, Center RJ, Li F, Bhat P, Ffrench R, et al. Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection. medRxiv [Preprint]. 2021 Jul 1:2021. 06.28.21259671. https://doi.org/10.1101/2021.06.28.21259671
    Search in Google ScholarBack to article
  10. Esbin MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection. RNA. 2020 Jul;26(7):771–783. https://doi.org/10.1261/rna.076232.120
    Search in Google ScholarBack to article
  11. Gudbjartsson DF, Norddahl GL, Melsted P, Gunnarsdot-tir K, Holm H, Eythorsson E, Arnthorsson AO, Helgason D, Bjarnadottir K, Ingvarsson RF, et al. Humoral immune response to SARS-CoV-2 in Iceland. N Engl J Med. 2020 Oct;383(18):1724–1734. https://doi.org/10.1056/NEJMoa2026116
    Search in Google ScholarBack to article
  12. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020 Jul;71(15):778–785. https://doi.org/10.1093/cid/ciaa310
    Search in Google ScholarBack to article
  13. Harley K, Gunsolus IL. Comparison of the clinical performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elec-sys Total SARS-CoV-2 antibody assays. J Clin Microbiol. 2020 Dec;59(1):10.1128/jcm.02104-20. https://doi.org/10.1128/jcm.02104-20
    Open DOISearch in Google ScholarBack to article
  14. Herroelen PH, Martens GA, De Smet D, Swaerts K, Decavele AS. Humoral immune response to SARS-CoV-2: Comparative clinical performance of seven commercial serology tests. Am J Clin Pathol. 2020 Oct;154(5):610–619. https://doi.org/10.1093/ajcp/aqaa140
    Search in Google ScholarBack to article
  15. Hou H, Wang T, Zhang B, Luo Y, Mao L, Wang F, Wu S, Sun Z. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clin Transl Immunology. 2020 May;9(5):e01136. https://doi.org/10.1002/cti2.1136
    Search in Google ScholarBack to article
  16. Hsueh PR, Huang LM, Chen PJ, Kao CL, Yang PC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect. 2004 Dec;10(12):1062–1066. https://doi.org/10.1111/j.1469-0691.2004.01009.x
    Search in Google ScholarBack to article
  17. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
    Search in Google ScholarBack to article
  18. Infantino M, Manfredi M, Grossi V, Lari B, Fabbri S, Benucci M, Fortini A, Damiani A, Mobilia EM, Panciroli M, et al. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies. J Med Virol. 2021 Mar;93(3):1436–1442. https://doi.org/10.1002/jmv.26422
    Search in Google ScholarBack to article
  19. Jääskeläinen AJ, Kekäläinen E, Kallio-Kokko H, Mannonen L, Kortela E, Vapalahti O, Kurkela S, Lappalainen M. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples. Euro Surveill. 2020 May;25(18):2000603. https://doi.org/10.2807/1560-7917.ES.2020.25.18.2000603
    Search in Google ScholarBack to article
  20. Jalkanen P, Pasternack A, Maljanen S, Melén K, Kolehmainen P, Huttunen M, Lundberg R, Tripathi L, Khan H, Ritvos MA, et al. A Combination of N and S antigens with IgA and IgG measurement strengthens the accuracy of SARS-CoV-2 serodiagnostics. J Infect Dis. 2021 Jul;224(2):218–228. https://doi.org/10.1093/infdis/jiab222
    Search in Google ScholarBack to article
  21. Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, Littlefield K, Kumar S, Naik HM, Betenbaugh MJ, et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020 Nov;130(11):6141–6150. https://doi.org/10.1172/JCI142004
    Search in Google ScholarBack to article
  22. Korte W, Buljan M, Rösslein M, Wick P, Golubov V, Jentsch J, Reut M, Peier K, Nohynek B, Fischer A, et al. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on. J Infect. 2021 Jan;82(1):e11–e14. https://doi.org/10.1016/j.jinf.2020.08.032
    Search in Google ScholarBack to article
  23. Li D, Li J. Immunologic testing for SARS-CoV-2 infection from the antigen perspective. J Clin Microbiol. 2021 Apr;59(5):10.1128/jcm. 02160-20. https://doi.org/10.1128/jcm.02160-20
    Search in Google ScholarBack to article
  24. Li N, Wang P, Wang X, Geng C, Chen J, Gong Y. Molecular diagnosis of COVID-19: Current situation and trend in China (Review). Exp Ther Med. 2020 Nov;20(5):13. https://doi.org/10.3892/etm.2020.9142
    Search in Google ScholarBack to article
  25. Lipsitch M, Grad YH, Sette A, Crotty S. Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nat Rev Immunol. 2020 Nov;20(11):709–713. https://doi.org/10.1038/s41577-020-00460-4
    Search in Google ScholarBack to article
  26. Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, Feng Y, Zhu C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020a Jun;505:172–175. https://doi.org/10.1016/j.cca.2020.03.009
    Search in Google ScholarBack to article
  27. Liu W, Liu L, Kou G, Zheng Y, Ding Y, Ni W, Wang Q, Tan L, Wu W, Tang S, et al. Evaluation of nucleocapsid and spike proteinbased enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol. 2020b May;58(6):10.1128/ jcm.00461-20. https://doi.org/10.1128/jcm.00461-20
    Search in Google ScholarBack to article
  28. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, Hu JL, Xu W, Zhang Y, Lv FJ, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020 Aug;26(8):1200–1204. https://doi.org/10.1038/s41591-020-0965-6
    Search in Google ScholarBack to article
  29. Lv H, Wu NC, Tsang OT, Yuan M, Perera RAPM, Leung WS, So RTY, Chan JMC, Yip GK, Chik TSH, et al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep. 2020 Jun;31(9):107725. https://doi.org/10.1016/j.celrep.2020.107725
    Search in Google ScholarBack to article
  30. Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou P, Cheng L, Li Y, Ma X, Jin T. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020 Jul;17(7):773 –775. https://doi.org/10.1038/s41423-020-0474-z
    Search in Google ScholarBack to article
  31. Masiá M, Telenti G, Fernández M, García JA, Agulló V, Padilla S, García-Abellán J, Guillén L, Mascarell P, Asenjo JC, et al. SARS-CoV-2 seroconversion and viral clearance in patients hospitalized with COVID-19: Viral load predicts antibody response. Open Forum Infect Dis. 2021 Jan 5;8(2):ofab005. https://doi.org/10.1093/ofid/ofab005
    Search in Google ScholarBack to article
  32. Montesinos I, Gruson D, Kabamba B, Dahma H, Van den Wijn-gaert S, Reza S, Carbone V, Vandenberg O, Gulbis B, Wolff F, et al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol. 2020 Jul;128:104413. https://doi.org/10.1016/j.jcv.2020.104413
    Search in Google ScholarBack to article
  33. Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V, Kouatchet A, Ducancelle A, Lunel-Fabiani F, Le Guillou-Guillemette H. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). J Clin Virol. 2020 Aug;129:104511. https://doi.org/10.1016/j.jcv.2020.104511
    Search in Google ScholarBack to article
  34. Nuccetelli M, Pieri M, Gisone F, Bernardini S. Combined anti-SARS-CoV-2 IgA, IgG, and IgM detection as a better strategy to prevent second infection spreading waves. Immunol Invest. 2022 Feb;51(2):233–245. https://doi.org/10.1080/08820139.2020.1823407
    Search in Google ScholarBack to article
  35. Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, Rosser EC, Webb K, Deakin CT. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020 Dec;11(1):6317. https://doi.org/10.1038/s41467-020-19741-6
    Search in Google ScholarBack to article
  36. Peeling RW, Wedderburn CJ, Garcia PJ, Boeras D, Fongwen N, Nkengasong J, Sall A, Tanuri A, Heymann DL. Serology testing in the COVID-19 pandemic response. Lancet Infect Dis. 2020 Sep;20(9):e245–e249. https://doi.org/10.1016/S1473-3099(20)30517-X
    Search in Google ScholarBack to article
  37. Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020 Apr;395(10230):1101–1102. https://doi.org/10.1016/S0140-6736(20)30788-1
    Search in Google ScholarBack to article
  38. Pieri M, Ciotti M, Carlozzi N, Frassanito ML, Meloni A, Cistera A, Turchetti G, Niscola S, Labate G, Calugi G, et al. SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection. Clin Chim Acta. 2020 Dec;511:28–32. https://doi.org/10.1016/j.cca.2020.09.033
    Search in Google ScholarBack to article
  39. Pisanic N, Randad PR, Kruczynski K, Manabe YC, Thomas DL, Pekosz A, Klein SL, Betenbaugh MJ, Clarke WA, Laeyendecker O, et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. J Clin Microbiol. 2020 Dec;59(1): 10.1128/jcm.02204-20. https://doi.org/10.1128/jcm.02204-20
    Open DOISearch in Google ScholarBack to article
  40. Qu J, Wu C, Li X, Zhang G, Jiang Z, Li X, Zhu Q, Liu L. Profile of immunoglobulin G and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Nov;71(16):2255–2258. https://doi.org/10.1093/cid/ciaa489
    Search in Google ScholarBack to article
  41. Sadiq S, Khan M, Sadiq T, Orakzai S, Dawood MM, Haq NU, Riaz N. Impact of age, gender, post infection and post vaccination status on antibody response in COVID 19 patients. J Pak Med Assoc. 2022 Sep;72(9):1805–1809. https://doi.org/10.47391/jpma.5309
    Search in Google ScholarBack to article
  42. Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, Hemmings O, O’Byrne A, Kouphou N, Galao RP, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020 Dec;5(12):1598–1607. https://doi.org/10.1038/s41564-020-00813-8
    Search in Google ScholarBack to article
  43. Sharma S, Shrivastava S, Kausley SB, Rai B, Pandit AB. Coronavirus: A comparative analysis of detection technologies in the wake of emerging variants. Infection. 2023 Feb;51(1):1–19. https://doi.org/10.1007/s15010-022-01819-6
    Search in Google ScholarBack to article
  44. Shi AC, Ren P. SARS-CoV-2 serology testing: Progress and challenges. J Immunol Methods. 2021 Jul;494:113060. https://doi.org/10.1016/j.jim.2021.113060
    Search in Google ScholarBack to article
  45. Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claёr L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021 Jan;13(577):eabd2223. https://doi.org/10.1126/scitranslmed.abd2223
    Search in Google ScholarBack to article
  46. Tang H, Tian JB, Dong JW, Tang XT, Yan ZY, Zhao YY, Xiong F, Sun X, Song CX, Xiang CG, et al. Serologic detection of SARS-CoV-2 infections in hemodialysis centers: A multicenter retrospective study in Wuhan, China. Am J Kidney Dis. 2020a Oct;76(4):490–499.e1. https://doi.org/10.1053/j.ajkd.2020.06.008
    Search in Google ScholarBack to article
  47. Tang MS, Hock KG, Logsdon NM, Hayes JE, Gronowski AM, Anderson NW, Farnsworth CW. Clinical performance of the Roche SARS-CoV-2 serologic assay. Clin Chem. 2020b Aug;66(8):1107–1109. https://doi.org/10.1093/clinchem/hvaa132
    Search in Google ScholarBack to article
  48. Tariq M, Hur J, Seo JW, Kim DY, Yun NR, Lee YM, Bang MS, Hwang SY, Kim CM, Lee JH, et al. Usefulness of ELISA using total antibody against plant-expressed recombinant nucleocapsid protein of SARS-CoV-2. Microbiol Spectr. 2021 Dec;9(3):e0067221. https://doi.org/10.1128/spectrum.00672-21
    Search in Google ScholarBack to article
  49. Theel ES, Slev P, Wheeler S, Couturier MR, Wong SJ, Kadkhoda K. The role of antibody testing for SARS-CoV-2: Is there one? J Clin Microbiol. 2020 Jul;58(8):10.1128/jcm.00797-20. https://doi.org/10.1128/jcm.00797-20
    Search in Google ScholarBack to article
  50. Tré-Hardy M, Wilmet A, Beukinga I, Favresse J, Dogné JM, Douxfils J, Blairon L. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021 Feb;93(2):803–811. https://doi.org/10.1002/jmv.26303
    Search in Google ScholarBack to article
  51. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, Chen H, Mubareka S, Gubbay JB, Chan WCW. Diagnosing COVID-19: The disease and tools for detection. ACS Nano. 2020 Apr;14(4):3822–3835. https://doi.org/10.1021/acsnano.0c02624
    Search in Google ScholarBack to article
  52. Van Elslande J, Decru B, Jonckheere S, Van Wijngaerden E, Houben E, Vandecandelaere P, Indevuyst C, Depypere M, Desmet S, André E, et al. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Clin Microbiol Infect. 2020 Nov;26(11):1557.e1–1557.e7. https://doi.org/10.1016/j.cmi.2020.07.038
    Search in Google ScholarBack to article
  53. Verkerke H, Horwath M, Saeedi B, Boyer D, Allen JW, Owens J, Arthur CM, Nakahara H, Rha J, Patel K, et al. Comparison of antibody class-specific SARS-CoV-2 serologies for the diagnosis of acute COVID-19. J Clin Microbiol. 2021 Mar;59(4):10.1128/jcm.02026-20. https://doi.org/10.1128/jcm.02026-20
    Open DOISearch in Google ScholarBack to article
  54. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Apr;181(2):281–292.e6. https://doi.org/10.1016/j.celL2020.02.058
    Search in Google ScholarBack to article
  55. Wang P. Significance of IgA antibody testing for early detection of SARS-CoV-2. J Med Virol. 2021 Apr;93(4):1888–1889. https://doi.org/10.1002/jmv.26703
    Search in Google ScholarBack to article
  56. Wang Q, Du Q, Guo B, Mu D, Lu X, Ma Q, Guo Y, Fang L, Zhang B, Zhang G, et al. A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays. J Clin Microbiol. 2020 May;58(6):10.1128/ jcm.00375-20. https://doi.org/10.1128/jcm.00375-20
    Open DOISearch in Google ScholarBack to article
  57. Watson J, Richter A, Deeks J. Testing for SARS-CoV-2 antibodies. BMJ. 2020 Sep;370:m3325. https://doi.org/10.1136/bmj.m3325
    Search in Google ScholarBack to article
  58. Xu M, O’Brien MP, Hooper AT, Forleo-Neto E, Isa F, Hou P, Chan KC, Cohen MS, Marovich MA, Hamilton JD, et al. Nasopharyngeal viral load is the major driver of incident antibody immune response to SARS-CoV-2 infection. Open Forum Infect Dis. 2023 Dec;10(12):ofad598. https://doi.org/10.1093/ofid/ofad598
    Search in Google ScholarBack to article
  59. Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020 Aug;56(2):2001526. https://doi.org/10.1183/13993003.01526-2020
    Search in Google ScholarBack to article
  60. Zervou FN, Louie P, Stachel A, Zacharioudakis IM, Ortiz-Mendez Y, Thomas K, Aguero-Rosenfeld ME. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol. 2021 Sep;93(9):5409–5415. https://doi.org/10.1002/jmv.27058
    Search in Google ScholarBack to article
  61. Zhai B, Clarke K, Bauer DL, Moehling Geffel KK, Kupul S, Schratz LJ, Nowalk MP, McElroy AK, McLachlan JB, Zimmerman RK, et al. SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients. J Immunol. 2022 Apr;208(7):1711–1718. https://doi.org/10.4049/jimmunol.2101156
    Search in Google ScholarBack to article
  62. Zhang J, Xiao T, Cai Y, Chen B. Structure of SARS-CoV-2 spike protein. Curr Opin Virol. 2021 Oct;50:173–182. https://doi.org/10.1016/j.coviro.2021.08.010
    Search in Google ScholarBack to article
  63. Zhang S, Wang L, Cheng G. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies. Mol Ther. 2022 May;30(5):1869–1884. https://doi.org/10.1016/j.ymthe.2022.02.014
    Search in Google ScholarBack to article
  64. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020 Nov;71(16):2027–2034. https://doi.org/10.1093/cid/ciaa344
    Search in Google ScholarBack to article
  65. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7
    Search in Google ScholarBack to article
DOI: https://doi.org/10.33073/pjm-2024-019 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Journal RSS Feed
Language: English
Page range: 123 - 130
Submitted on: Feb 29, 2024
Accepted on: Apr 22, 2024
Published on: Jun 20, 2024
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
early detection,
IgA isotype,
kinetics of antibodies,
SARS-CoV-2,
serological test
Related subjects:
Life sciences,
Microbiology and virology

© 2024 Pei Wang, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 73 (2024): Issue 2 (June 2024)Next article